FRM
MGNX icon

Fox Run Management’s MacroGenics MGNX Stock Holding History

Fox Run Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,542
Closed -$93.8K – 875
2023
Q2 		$93.8K Sell
17,542
-10,144
-37% -$62.6K 0.03% 636
2023
Q1 		$199K Sell
27,686
-8,437
-23% -$50.8K 0.06% 533
2022
Q4 		$242K Buy
+36,123
New +$198K 0.1% 419
2022
Q1 		– Sell
-11,791
Closed -$189K – 628
2021
Q4 		$189K Buy
+11,791
New +$222K 0.11% 374
2020
Q3 		– Sell
-9,335
Closed -$261K – 265
2020
Q2 		$261K Buy
+9,335
New +$162K 0.35% 145
2018
Q3 		– Sell
-15,303
Closed -$316K – 727
2018
Q2 		$316K Buy
+15,303
New +$345K 0.1% 412

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fox Run Management's MGNX Position: Q3 2023 in Review

Fox Run Management sold out of MacroGenics (MGNX) in Q3 2023, closing a stake of 17,542 shares — an estimated $93.8K sold.

Fox Run Management first reported a position in MGNX in Q2 2018 and held it in 6 quarters. The position peaked at $316K in Q2 2018. 127 funds tracked by Wall St. Rank hold MGNX as of Q3 2023.

  • Fox Run Management reported no remaining MacroGenics position as of Q3 2023 after selling out during the quarter.
  • Fox Run Management sold 17,542 MacroGenics shares in Q3 2023, an estimated $93.8K.
  • Fox Run Management first reported a position in MacroGenics in Q2 2018 and held it in 6 quarters.
  • Fox Run Management's MacroGenics position peaked at $316K in Q2 2018.
  • 127 funds tracked by Wall St. Rank held MacroGenics as of Q3 2023.

Based on Fox Run Management's 13F filing for Q3 2023, filed 7 Nov 2023.